Xylem Inc (NYSE:XYL) Expected to Post Quarterly Sales of $999.71 Million

Wall Street brokerages predict that Xylem Inc (NYSE:XYL) will announce $999.71 million in sales for the current quarter, Zacks reports. Seven analysts have made estimates for Xylem’s earnings, with the lowest sales estimate coming in at $961.00 million and the highest estimate coming in at $1.05 billion. Xylem posted sales of $1.35 billion during the same quarter last year, which suggests a negative year over year growth rate of 25.9%. The business is expected to announce its next earnings results on Thursday, August 6th.

According to Zacks, analysts expect that Xylem will report full-year sales of $4.63 billion for the current fiscal year, with estimates ranging from $4.33 billion to $5.41 billion. For the next fiscal year, analysts anticipate that the business will report sales of $5.03 billion, with estimates ranging from $4.72 billion to $5.68 billion. Zacks’ sales calculations are a mean average based on a survey of analysts that cover Xylem.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, May 5th. The industrial products company reported $0.23 EPS for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.14). The firm had revenue of $1.12 billion during the quarter, compared to the consensus estimate of $1.15 billion. Xylem had a net margin of 7.01% and a return on equity of 17.08%. The business’s revenue for the quarter was down 9.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.52 earnings per share.

Several research firms recently issued reports on XYL. Oppenheimer reiterated a “hold” rating on shares of Xylem in a report on Thursday, June 4th. Zacks Investment Research lowered Xylem from a “hold” rating to a “sell” rating and set a $73.00 target price on the stock. in a report on Monday, April 27th. Atlantic Securities lowered Xylem from an “overweight” rating to a “neutral” rating and set a $75.00 target price on the stock. in a report on Tuesday, March 31st. Berenberg Bank raised Xylem from a “sell” rating to a “hold” rating in a research report on Thursday, March 26th. Finally, Citigroup lowered their price target on Xylem from $68.00 to $66.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 6th. Three research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have assigned a buy rating to the company’s stock. Xylem has an average rating of “Hold” and a consensus target price of $68.43.

Shares of Xylem stock traded up $1.00 during trading on Friday, reaching $63.16. The stock had a trading volume of 3,189,624 shares, compared to its average volume of 1,345,259. Xylem has a 52 week low of $54.62 and a 52 week high of $89.34. The company has a market capitalization of $11.18 billion, a price-to-earnings ratio of 31.74, a P/E/G ratio of 4.35 and a beta of 1.02. The company has a current ratio of 1.55, a quick ratio of 1.19 and a debt-to-equity ratio of 0.72. The stock has a fifty day moving average price of $64.78 and a two-hundred day moving average price of $73.37.

The company also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th were paid a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a dividend yield of 1.65%. The ex-dividend date of this dividend was Wednesday, May 27th. Xylem’s payout ratio is 34.44%.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Royal Bank of Canada lifted its stake in shares of Xylem by 34.7% in the 1st quarter. Royal Bank of Canada now owns 869,977 shares of the industrial products company’s stock valued at $56,663,000 after acquiring an additional 223,913 shares during the last quarter. Telemus Capital LLC acquired a new stake in Xylem in the first quarter valued at $418,000. The Manufacturers Life Insurance Company increased its holdings in Xylem by 26.7% in the first quarter. The Manufacturers Life Insurance Company now owns 422,739 shares of the industrial products company’s stock valued at $27,533,000 after purchasing an additional 89,153 shares during the period. FDx Advisors Inc. increased its holdings in Xylem by 146.2% in the first quarter. FDx Advisors Inc. now owns 11,305 shares of the industrial products company’s stock valued at $736,000 after purchasing an additional 6,713 shares during the period. Finally, Clearbridge Investments LLC increased its holdings in Xylem by 4.1% in the first quarter. Clearbridge Investments LLC now owns 98,527 shares of the industrial products company’s stock valued at $6,417,000 after purchasing an additional 3,903 shares during the period. Institutional investors own 85.88% of the company’s stock.

About Xylem

Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.

Recommended Story: Dollar Cost Averaging

Get a free copy of the Zacks research report on Xylem (XYL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.